Related content

Role of the novel HSP90 inhibitor AUY922 in hepatocellular carcinoma: Potential for therapy

By                

Molecular Medicine Reports, Vol. 12, Iss. 2, 2015-01 ,pp. : 2451-2456

Spandidos Publications

Access to resources Recommend Favorite

Hsp90 inhibitor NVP-AUY922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors

By  

Oncology Reports, Vol. 33, Iss. 3, 2015-01 ,pp. : 1499-1504

Spandidos Publications

Access to resources Recommend Favorite

Antiproliferative effect of the HSP90 inhibitor NVP-AUY922 is determined by the expression of PTEN in esophageal cancer

By                    

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 45-50

Spandidos Publications

Access to resources Recommend Favorite

Recent Advances in Hsp90 Inhibitors as Antitumor Agents

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 7, 2008-10 ,pp. : 761-782

Bentham Science Publishers

Access to resources Recommend Favorite

The selective Hsp90 inhibitor BJ-B11 exhibits potent antitumor activity via induction of cell cycle arrest, apoptosis and autophagy in Eca-109 human esophageal squamous carcinoma cells

By                      

International Journal of Oncology, Vol. 41, Iss. 6, 2012-01 ,pp. : 2276-2284

Spandidos Publications

Access to resources Recommend Favorite